The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
解鎖市場時間軸與訊號動態
過去 90 日內有 4 個訊號。
此公司進入各市場的次序 — 由最舊至最新
Medical Sales Representative
Medical Sales Representative
註冊以查看完整訊號動態
MENARINI Group 的國際擴張與競爭對手的比較
MENARINI Group你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 MENARINI Group你 | 2 | 0 | -67% | 4 | 12 |
Global Commercial Metrics Associate
查看招聘Florence, Tuscany, Italy · 上星期
Global Platforms Operations Associate - 12‑month fixed‑term contract
查看招聘Florence, Tuscany, Italy · 2星期前
Data Management Associate
查看招聘Florence, Tuscany, Italy · 2星期前
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
中國啟動帶狀疱疹中西醫結合診療專家共識全國巡講,覆蓋31個省份,為期一年,由美納里尼支持,推動規範化診療落地。
Menarini集團和Stemline Therapeutics宣布在2026年ASCO年會上發表七項演講,展示elacestrant和tagraxofusp在實體腫瘤和血液惡性腫瘤中的數據,包括轉移性乳癌的聯合療法。
美納里尼集團及Stemline Therapeutics將在2026年ASCO年會上展示elacestrant和tagraxofusp的新數據,涵蓋實體腫瘤和血液惡性腫瘤共七項報告。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 MENARINI Group 業務、市場及增長訊號的快速解答。
